Ebola vaccination begins in the Democratic Republic of the Congo
14 September 2025
Bulape, Democratic Republic of the Congo — Vaccination of frontline health workers and contacts of people infected with Ebola virus disease has begun in Bulape health zone in the Democratic Republic of the Congo’s Kasai Province where an outbreak of the disease has been declared.
An initial 400 doses of the Ervebo Ebola vaccine—from the country’s stockpile of 2000 doses prepositioned in the capital Kinshasa—have been delivered to Bulape, one of the current hotspots of the outbreak. Additional doses will be delivered to the affected localities in the coming days.
The vaccine is being administered through ring vaccination strategy, which entails vaccinating individuals at highest risk of infection after having come into contact with a patient confirmed with the virus. It is also recommended for health care and frontline workers responding to the outbreak who may be in contact with Ebola patients. The Ervebo vaccine is safe and protects against the Zaire ebolavirus species, which has been confirmed as the cause of the ongoing outbreak.
The International Coordinating Group on Vaccine Provision has approved around 45 000 additional Ebola vaccine doses to be shipped to the Democratic Republic of the Congo as part of the ongoing outbreak response. WHO supported the health authorities to develop the request for additional doses, and with partners, including UNICEF, also supported the development of a vaccination plan for the rollout of the doses. Vaccination teams are also being trained in data collection and receiving field support.
In addition to the vaccines, treatment courses of the monoclonal antibody therapy (Mab114) drug have also been sent to treatment centres in Bulape for clinical care.
On the ground, WHO has so far deployed 48 experts in disease surveillance, clinical care, infection prevention and control, logistics and community engagement who, along with partner organizations, are supporting the government to rapidly strengthen outbreak response measures to halt the spread of the virus.
In countries neighbouring the Democratic Republic of Congo, WHO is working with national authorities to bolster operational readiness to enable rapid detection of cases and prompt initiation of measures to curb further spread.
WHO assesses the overall public health risk posed by the ongoing outbreak as high at the national level, moderate at the regional level and low at the global level.
https://www.afro.who.int/countries/democratic-republic-of-congo/news/ebola-vaccination-begins-democratic-republic-congo?country=Democratic%20Republic%20of%20Congo&n ame=Democratic%20Republic%20of%20Congo
-----------------------------------------------------------------------------
Translation Google
Kasai: 360 doses of Ebola vaccine arrive in Bulape
September 14, 2025
Tshikapa, September 14, 2025 (ACP).- Three hundred and sixty (360) doses of vaccine against Ebola hemorrhagic fever were received in the Bulape health zone, Mweka territory, Kasai province, in the center of the Democratic Republic of Congo, announced Sunday, the coordinator of the response on site during the reception.
"The first batch of 360 vaccine doses was received in the Bulape health zone this weekend. Vaccination teams have already been briefed, and the campaign will begin this Sunday. Patient care with the Ebanga molecule had already begun. The advantage of the arrival of these vaccines is that care will now be better provided, in accordance with standards," said Matthias Mossoko, response coordinator in Bulape.
He also called on the population to strictly respect barrier measures in order to limit the spread of the epidemic and avoid further deaths.
As of Sunday, September 14, 2025, 27 confirmed cases have been recorded in the Bulape health zone, including 16 deaths, as well as more than 50 suspected cases.
ACP/ CL
https://acp.cd/sante/kasai-arrivee-de-360-doses-de-vaccin-contre-la-fievre-ebola-a-bulape/
---------------------------------------------------------------------------------------
Government launches Ebola vaccination in Bulape
Published on Sun, 09/14/2025 - 5:15 PM | Modified on Sun, 09/14/2025 - 8:23 PM
The fight against the Ebola epidemic declared in the Bulape health zone, Kasai province, is entering an active phase. The government has launched vaccination against the virus, the World Health Organization (WHO) announced this Sunday, September 14. This vaccination is targeting frontline healthcare workers and contacts of infected people, according to the so-called ring vaccination strategy.
With the support of DRC partners, including the WHO, a first batch of 400 doses of the Ervebo vaccine, from the national stockpile of 2,000 doses pre-positioned in Kinshasa, was sent to Bulape, identified as one of the epicenters of the epidemic. Other doses will be sent to affected areas in the coming days, according to the WHO press release. The Ervebo vaccine protects against the Zaire ebolavirus species, responsible for the current epidemic.
The International Coordinating Group for Vaccine Procurement has approved the shipment of an additional 45,000 doses to the DRC. WHO supported health authorities in submitting this request and developing the vaccination plan. Field teams are also being trained in data collection and are receiving technical support.
Treatments and expertise deployed
Monoclonal antibody treatments (Mab114) were sent to treatment centers in Bulape to improve clinical management. WHO mobilized 48 experts specialized in epidemiological surveillance, clinical care, logistics, infection prevention, and community engagement.
In neighboring countries, WHO is working with national authorities to strengthen operational preparedness, enabling rapid case detection and immediate response. The organization assesses the health risk as high at the national level, moderate at the regional level, and low at the global level.
The Bulape health zone is facing significant logistical and health challenges. Local authorities have welcomed the arrival of vaccines and treatments, while calling for community mobilization to facilitate the response. Awareness campaigns are underway to encourage the population to cooperate with medical teams and promptly report suspected cases.
Epidemic on the rise
As of September 14, the Ebola virus has already affected 81 people, including 28 deaths, representing a fatality rate of 34.6% in the Bulape region, since the official declaration of the epidemic on September 4. 58 new contacts have been identified, bringing to 716 the number of people who have been in contact with carriers of the virus.
https://www.radiookapi.net/2025/09/...ment-lance-la-vaccination-contre-ebola-bulape